Literature DB >> 10567986

An update on the pathophysiology of rhinovirus upper respiratory tract infections.

M van Kempen1, C Bachert, P Van Cauwenberge.   

Abstract

Upper respiratory tract infections are one of the most common infectious diseases in man and are characterized by relatively mild symptoms. However, complications of bacterial super-infection or asthma exacerbations are not seldomly seen. Most upper respiratory tract infections are caused by rhinoviruses. The rhinovirus is a non-enveloped 30 nm RNA-virus with over 100 serotypes that belongs to the Picornaviridae family and only replicates in primates. It is characterized by a single positive stranded genome acting not only as a template for RNA synthesis, but also encoding for a single polypeptide necessary for viral replication. The viral capsid has an icosahedral symmetry and demonstrates deep canyons, with a receptor-binding domain. Rhinoviruses are transmitted mainly via direct- or indirect contact with infected secretions and invade their host by binding to the ICAM-1 receptor on the nasal epithelium. Typical for rhinovirus upper respiratory tract infections are isolated scattered foci of infected epithelium, not showing any striking damage or cytopathic alterations, between large areas of normal epithelium. Today there is still little detailed knowledge on the pathophysiology of common cold, especially on the aspect of cellular migration and defense. A better understanding in mechanisms underlying this cellular response would not only have therapeutical consequences, but may also explain the relationship between viral infectious rhinitis and asthma or atopy. During a rhinovirus infection, a selective neutrophil and monocyte recruitment is observed. In vitro and in vivo data have demonstrated a time-limited, rhinovirus-induced increase in bradykinin, cytokine, chemokine and sICAM-1 concentrations. Epithelial derived proinflammatory cytokines initiate an adhesion cascade and activate T lymphocytes that create a TH1-type cytokine environment within the infected tissue, necessary to eradicate the virus infection. The selective recruitment of neutrophils seems linked to increased concentrations of the chemokine IL-8 and common cold symptoms. It is doubtful that the cytokine-regulated-production of specific neutralising immunoglobulins is necessary for recovery from viral illnesses and presumably only contributes to a late and temporary protection against rhinovirus reinfection. These observations confirm the crucial role that cytokines and mediators play in the pathogenesis of a rhinovirus infection by mediating chemotaxis, transmigration and activation of inflammatory- and immunocompetent cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567986

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  22 in total

1.  Isolation and characterization of avian metapneumovirus from chickens in Korea.

Authors:  Ji-Sun Kwon; Hyun-Jeong Lee; Seung-Hwan Jeong; Jeong-Yong Park; Young-Ho Hong; Youn-Jeong Lee; Ho-Sik Youn; Dong-Woo Lee; Sun-Hee Do; Seung-Yong Park; In-Soo Choi; Joong-Bok Lee; Chang-Seon Song
Journal:  J Vet Sci       Date:  2010-03       Impact factor: 1.603

2.  Validation of the Nasal Mucus Index, a novel measurement of acute respiratory infection severity.

Authors:  Paul M Dorresteijn; Daniel Muller; Yaoguo Xie; Zhengjun Zhang; Bruce P Barrett
Journal:  Am J Rhinol Allergy       Date:  2016-09       Impact factor: 2.467

3.  Species-specific and cross-reactive IgG1 antibody binding to viral capsid protein 1 (VP1) antigens of human rhinovirus species A, B and C.

Authors:  Jua Iwasaki; Wendy-Anne Smith; Shane R Stone; Wayne R Thomas; Belinda J Hales
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

4.  Longer latency of sensory response to intravenous odor injection predicts olfactory neural disorder.

Authors:  Shu Kikuta; Yu Matsumoto; Akihito Kuboki; Tsuguhisa Nakayama; Daiya Asaka; Nobuyoshi Otori; Hiromi Kojima; Takashi Sakamoto; Kashio Akinori; Kaori Kanaya; Rumi Ueha; Ryoji Kagoya; Hironobu Nishijima; Makiko Toma-Hirano; Yayoi Kikkawa; Kenji Kondo; Koichi Tsunoda; Tempei Miyaji; Takuhiro Yamaguchi; Kazunori Kataoka; Kensaku Mori; Tatsuya Yamasoba
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

Review 5.  Endotype-driven treatment in chronic upper airway diseases.

Authors:  Glynnis De Greve; Peter W Hellings; Wytske J Fokkens; Benoit Pugin; Brecht Steelant; Sven F Seys
Journal:  Clin Transl Allergy       Date:  2017-07-12       Impact factor: 5.871

Review 6.  A Role for Neutrophils in Viral Respiratory Disease.

Authors:  Jeremy V Camp; Colleen B Jonsson
Journal:  Front Immunol       Date:  2017-05-12       Impact factor: 7.561

Review 7.  Time to Say Goodbye to Bronchiolitis, Viral Wheeze, Reactive Airways Disease, Wheeze Bronchitis and All That.

Authors:  Konstantinos Douros; Mark L Everard
Journal:  Front Pediatr       Date:  2020-05-05       Impact factor: 3.418

Review 8.  Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?

Authors:  Giovanni A Rossi; Oliviero Sacco; Antonino Capizzi; Paola Mastromarino
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  Synergism between rhinovirus infection and oxidant pollutant exposure enhances airway epithelial cell cytokine production.

Authors:  E William Spannhake; Sekhar P M Reddy; David B Jacoby; Xiao-Ying Yu; Bahman Saatian; Jingyan Tian
Journal:  Environ Health Perspect       Date:  2002-07       Impact factor: 9.031

10.  Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study).

Authors:  Francesca Jaume; Llorenç Quintó; Isam Alobid; Joaquim Mullol
Journal:  BMJ Open       Date:  2018-01-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.